Sherief, L., Elmalky, M., Bayoumi, S., Talat, S. (2020). Screening for Hepatitis C Virus (HCV) Infection in Acute Lymphoblastic Leukemia (ALL) Survivors in The Hematology and Oncology Department of Children Hospital Zagazig University. The Egyptian Journal of Hospital Medicine, 80(1), 662-665. doi: 10.21608/ejhm.2020.93891
Laila Metwaly Sherief; Mohamed AbdelKader Elmalky; Sameh Saber Bayoumi; Sherif Mamdoh Talat. "Screening for Hepatitis C Virus (HCV) Infection in Acute Lymphoblastic Leukemia (ALL) Survivors in The Hematology and Oncology Department of Children Hospital Zagazig University". The Egyptian Journal of Hospital Medicine, 80, 1, 2020, 662-665. doi: 10.21608/ejhm.2020.93891
Sherief, L., Elmalky, M., Bayoumi, S., Talat, S. (2020). 'Screening for Hepatitis C Virus (HCV) Infection in Acute Lymphoblastic Leukemia (ALL) Survivors in The Hematology and Oncology Department of Children Hospital Zagazig University', The Egyptian Journal of Hospital Medicine, 80(1), pp. 662-665. doi: 10.21608/ejhm.2020.93891
Sherief, L., Elmalky, M., Bayoumi, S., Talat, S. Screening for Hepatitis C Virus (HCV) Infection in Acute Lymphoblastic Leukemia (ALL) Survivors in The Hematology and Oncology Department of Children Hospital Zagazig University. The Egyptian Journal of Hospital Medicine, 2020; 80(1): 662-665. doi: 10.21608/ejhm.2020.93891
Screening for Hepatitis C Virus (HCV) Infection in Acute Lymphoblastic Leukemia (ALL) Survivors in The Hematology and Oncology Department of Children Hospital Zagazig University
1Department of Pediatrics, Faculty of Medicine, Zagazig University
2Department of Radiology, Faculty of Medicine, Zagazig University
Abstract
Background: Acute lymphoblastic leukemia (ALL) survivors received blood transfusions for multiple times during treatment are at great risk for HCV infection. Rapid progression to cirrhosis in those patients is a concern for cancer survivors because of the immunosuppression from cancer-related treatment. Objective: Our study aimed to screen for (HCV) infection in acute lymphoblastic leukemia (ALL) survivors. Patients and methods: This cross-sectional study was conducted in the Hematology and Oncology Department of Children Hospital-Zagazig University on 80 cancer survivors collected over a period of 6 months from September 2018 to February 2019. Results: 70% of ALL survivors were HCV positive. Conclusion: ALL survivors are at great risk for acquiring HCV infection from the repeated blood and blood products transfusions with supsequent development of liver comorbitidites later on.